Alembic Limited (BOM:506235)

Market Cap	25.63B
Revenue (ttm)	2.11B
Net Income (ttm)	3.14B
Shares Out	256.78M
EPS (ttm)	12.24
PE Ratio	8.15
Forward PE	n/a
Dividend	2.40 (2.40%)
Ex-Dividend Date	Aug 5, 2024

Volume	25,046
Average Volume	53,797
Open	106.30
Previous Close	106.24
Day's Range	100.50 - 106.30
52-Week Range	85.55 - 169.00
Beta	0.89
RSI	46.55
Earnings Date	May 9, 2025

About Alembic

Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. It manufactures and markets fermentation and chemistry based on active pharmaceutical ingredient; and engages in research and development. In addition, it is involved in power generation through co-generation ...

• Industry: Real Estate
• Founded: 1907
• Employees: 285
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506235

Financial Performance

In 2023, Alembic's revenue was 1.57 billion, an increase of 23.77% compared to the previous year's 1.27 billion. Earnings were 2.69 billion, an increase of 40.90%.